-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2025.
- InMed Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $26.7K, a 31.4% decline year-over-year.
- InMed Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $119K, a 13.4% decline year-over-year.
- InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2025 was $119K, a 13.4% decline from 2024.
- InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2024 was $138K, a 50.5% decline from 2023.
- InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $278K, a 60.1% decline from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)